| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |